Men's Health
News
Prostate cancer screening for men over 50 has declined
Key clinical point: Prostate cancer screening rates among men aged 50 years and older declined nationwide from 2010 to 2013. Major finding: From...
Conference Coverage
ASCO: Research IDs new subtype of refractory prostate cancer
Key clinical point: Researchers have identified an aggressive new histologic subset of metastatic castration-resistant prostate cancer. Major...
News
AACE: Endocrine treatment of childhood cancer survivors needs improvement
Hypogonadism, hypopituitarism, and ovarian failure loom large for adult survivors of childhood cancer.
Conference Coverage
Men with cardiac concerns at risk for hypogonadism
Key clinical point: Symptomatic hypogonadism appears to be very common among men with heart problems. Major finding: The rate of symptomatic...
Conference Coverage
AUA: Testosterone may not deserve its reputation as a cardiovascular culprit
Does testosterone supplementation put men at risk for cardiovascular events? Current data point to “no.”
News
Severe acne erupts during transgender transition
News
Later colorectal cancer risk linked to high BMI, inflammation in adolescence
High BMIs and inflammation during adolescence are associated with colorectal cancer risk in midlife.
Conference Coverage
ATS: Study confirms strong association between sleep apnea, depression
Key clinical point: Patients who present for OSA or depression should be screened for both. Major finding: Patients with previously undiagnosed...
Conference Coverage
AUA: Very low-risk prostate cancers cause few deaths over 15 years
NEW ORLEANS – Long-term active surveillance seems to be a safe and effective way to avoid overtreatment in men with low- and very low-risk...
Conference Coverage
AACE: Free testosterone, prolactin levels signal MRI need in men with secondary hypogonadism
Key clinical point: Lab values can guide imaging decisions in men with pituitary adenomas. Major finding: Men with pituitary adenomas had...
Conference Coverage
ASCO: Upfront chemo prolongs life in men with advanced, hormone-naive prostate cancer
Key clinical point: Addition of chemotherapy to first-time hormone therapy improves survival in men with advanced prostate cancer. Major finding:...